Use of psychoactive substances and alcohol during the first three waves of the COVID-19 pandemic: Croatian experience

J Addict Dis. 2024 Apr-Jun;42(2):91-102. doi: 10.1080/10550887.2022.2145076. Epub 2022 Nov 29.

Abstract

Increased prevalence and severity of both substance and behavioral addictions are among the most harmful consequences of the COVID-19 outbreak.

To determine the sociodemographic characteristics, COVID-19-related stressors, and stress, anxiety, and depression symptoms that may predict the use and changes in the use of psychoactive substances (PS) during the first three COVID-19 waves in Croatia.

The cross-sectional online survey included 1,118 adult participants (220 men and 898 women; mean age: 35.1 [SD = 12.3] years; age range: 18-78) from general adult population. Sociodemographic data were collected, and ad-hoc developed questionnaires on COVID-19-related stressors, PS use before and during the pandemic, CAGE Alcohol Questionnaire, Impact of Event Scale, and Hospital Anxiety Depression Scale were applied.

The PS use increased in 31% of participants. The use of tobacco, caffeine, alcohol, cannabinoids, and anxiolytics showed the greatest increase in the last year (tobacco 7.1%; caffeine 5.8%; alcohol 6.4%; cannabinoids 2.5%; and anxiolytics 3.9%). Alcohol consumption during the pandemic increased in 16.8% of participants who consumed alcohol before the pandemic, with 4.5% of them reporting problematic alcohol use (PAU). The tested model demonstrated relatively good model-data fit and significantly predicted 11.8% increase in the use of PS and 9.8% of PAU.

Being married or in a relationship and severe anxiety and depression symptoms predicted increased use of PS and PAU, while higher education level and ever being diagnosed with COVID-19 predicted only increased use of PS.

Keywords: COVID-19; PS and alcohol use; anxiety; depression; stress.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Anxiety Agents*
  • Anxiety / epidemiology
  • COVID-19* / epidemiology
  • Caffeine
  • Cannabinoids*
  • Croatia / epidemiology
  • Cross-Sectional Studies
  • Depression / epidemiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pandemics
  • SARS-CoV-2
  • Young Adult

Substances

  • Anti-Anxiety Agents
  • Caffeine
  • Cannabinoids